Search Results - "Kott, Katharine A"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    A hierarchical approach to removal of unwanted variation for large-scale metabolomics data by Kim, Taiyun, Tang, Owen, Vernon, Stephen T., Kott, Katharine A., Koay, Yen Chin, Park, John, James, David E., Grieve, Stuart M., Speed, Terence P., Yang, Pengyi, Figtree, Gemma A., O’Sullivan, John F., Yang, Jean Yee Hwa

    Published in Nature communications (17-08-2021)
    “…Liquid chromatography-mass spectrometry-based metabolomics studies are increasingly applied to large population cohorts, which run for several weeks or even…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease by Kott, Katharine A, Genetzakis, Elijah, Gray, Michael P, Hansen, Peter, McGuire, Helen M, Yang, Jean Y, Grieve, Stuart M, Vernon, Stephen T, Figtree, Gemma A

    Published in Biomolecules (Basel, Switzerland) (29-07-2023)
    “…Risk-factor-based scoring systems for atherosclerotic coronary artery disease (CAD) remain concerningly inaccurate at the level of the individual and would…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review by Saleh, Soloman, George, Jacob, Kott, Katharine A., Meikle, Peter J., Figtree, Gemma A.

    Published in Frontiers in cardiovascular medicine (02-06-2022)
    “…As a leading cause of mortality and morbidity worldwide, cardiovascular disease and its diagnosis, quantification, and stratification remain significant health…”
    Get full text
    Journal Article
  7. 7

    Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study by Vernon, Stephen T, Tang, Owen, Kim, Taiyun, Chan, Adam S, Kott, Katharine A, Park, John, Hansen, Thomas, Koay, Yen C, Grieve, Stuart M, O'Sullivan, John F, Yang, Jean Y, Figtree, Gemma A

    Published in Cells (Basel, Switzerland) (22-04-2021)
    “…Despite effective prevention programs targeting cardiovascular risk factors, coronary artery disease (CAD) remains the leading cause of death. Novel biomarkers…”
    Get full text
    Journal Article
  8. 8

    Biomarker Development in Cardiology: Reviewing the Past to Inform the Future by Kott, Katharine A, Bishop, Michael, Yang, Christina H J, Plasto, Toby M, Cheng, Daniel C, Kaplan, Adam I, Cullen, Louise, Celermajer, David S, Meikle, Peter J, Vernon, Stephen T, Figtree, Gemma A

    Published in Cells (Basel, Switzerland) (08-02-2022)
    “…Cardiac biomarkers have become pivotal to the clinical practice of cardiology, but there remains much to discover that could benefit cardiology patients. We…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Utilizing state‐of‐the‐art “omics” technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease by Vernon, Stephen T., Hansen, Thomas, Kott, Katharine A., Yang, Jean Y., O'Sullivan, John F., Figtree, Gemma A.

    Published in Microcirculation (New York, N.Y. 1994) (01-02-2019)
    “…Identification of the four standard modifiable cardiovascular risk factors (SMuRFs)—diabetes mellitus, hyperlipidaemia, hypertension, and cigarette smoking—has…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study by Vernon, Stephen T., Kott, Katharine A., Hansen, Thomas, Zhang, Kimble J., Cole, Ben R., Coffey, Sean, Grieve, Stuart M., Figtree, Gemma A.

    Published in Atherosclerosis (01-09-2021)
    “…Targeting the modifiable risk factors for coronary artery disease (CAD) has substantial impact at the community level. However, it is not uncommon for…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Abstract 16324: The Overall Haemostatic Potential: A Novel Coagulation Measure Associated With Sex-specific Differences in Early Atherosclerosis and Metabolic Dysfunction by Kott, Katharine A, Morel-Kopp, Marie-Christine, Vernon, Stephen T, Takagi, Yuki, Ward, Christopher, Figtree, Gemma A

    Published in Circulation (New York, N.Y.) (17-11-2020)
    “…Introduction & AimPlaque micro-ruptures and associated thrombosis are a contributor to the progression of coronary artery disease (CAD). We sought to determine…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors by Figtree, Gemma A., Vernon, Stephen T., Harmer, Jason A., Gray, Michael P., Arnott, Clare, Bachour, Eric, Barsha, Giannie, Brieger, David, Brown, Alex, Celermajer, David S., Channon, Keith M., Chew, Nicholas W.S., Chong, James J.H., Chow, Clara K., Cistulli, Peter A., Ellinor, Patrick T., Grieve, Stuart M., Guzik, Tomasz J., Hagström, Emil, Jenkins, Alicia, Jennings, Garry, Keech, Anthony C., Kott, Katharine A., Kritharides, Leonard, Mamas, Mamas A., Mehran, Roxana, Meikle, Peter J., Natarajan, Pradeep, Negishi, Kazuaki, O’Sullivan, John, Patel, Sanjay, Psaltis, Peter J., Redfern, Julie, Steg, Philippe G., Sullivan, David R., Sundström, Johan, Vogel, Birgit, Wilson, Andrew, Wong, Dennis, Bhatt, Deepak L., Kovacic, Jason C., Nicholls, Stephen J., Ademi, Zanfina, Avis, Suzanne Robyn, Chan, Adam, Contreras, Osvaldo, Coorey, Craig P., Fathieh, Sina, Genetzakis, Elijah, Gholipour, Alireza, Giles, Corey, Hollings, Matthew, Hyun, Karice, Kazi, Samia, Kovacic, Jason C., Larance, Mark, Marathe, Jessica A., Marquina, Clara, Nelson, Adam, Ng, Hooi Hooi, Patrick, Ellis, Peter, Karlheinz, Tran, Andy, Yang, Jean, Zhu, Dantong, Zwack, Clara

    “…Reducing the incidence and prevalence of standard modifiable cardiovascular risk factors (SMuRFs) is critical to tackling the global burden of coronary artery…”
    Get full text
    Journal Article